ACTHREL by Ferring Pharmaceuticals is clinical pharmacology pharmacodynamics in normal subjects, intravenous administration of corticorelin results in a rapid and sustained increase of plasma acth levels and a near parallel increase of plasma cortisol. First approved in 1996.
Drug data last refreshed 9h ago · AI intelligence enriched 6d ago
ACTHREL (corticorelin) is a synthetic corticotropin-releasing hormone (CRH) analog administered by intravenous injection that stimulates ACTH and cortisol release for diagnostic testing of hypothalamic-pituitary-adrenal (HPA) axis function. It is used to differentiate causes of adrenocorticotropin (ACTH) abnormalities and evaluate pituitary and adrenal function in patients with suspected endocrine disorders.
Product lifecycle is approaching loss of exclusivity; brand team focus likely shifting to generic defense and niche market retention rather than growth expansion.
CLINICAL PHARMACOLOGY Pharmacodynamics In normal subjects, intravenous administration of corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition, intravenous administration of corticorelin to normal subjects causes a…
Worked on ACTHREL at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on ACTHREL offers exposure to specialty diagnostic pharmaceuticals and niche market management, but limited growth trajectory given LOE-approaching status. Career advancement depends on contributing to strategic LOE planning, generic defense, or transition to adjacent endocrine products.